Eric Samorodnitsky

1.0k total citations
22 papers, 650 citations indexed

About

Eric Samorodnitsky is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Eric Samorodnitsky has authored 22 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Eric Samorodnitsky's work include Fibroblast Growth Factor Research (7 papers), Cancer Genomics and Diagnostics (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Eric Samorodnitsky is often cited by papers focused on Fibroblast Growth Factor Research (7 papers), Cancer Genomics and Diagnostics (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Eric Samorodnitsky collaborates with scholars based in United States, Puerto Rico and Russia. Eric Samorodnitsky's co-authors include Julie W. Reeser, Michele R. Wing, Jharna Miya, Sameek Roychowdhury, Senthilkumar Damodaran, Jharna Datta, Darshna Bhatt, Sukla Roychowdhury, Raffi Hagopian and Hui‐Zi Chen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Eric Samorodnitsky

21 papers receiving 643 citations

Peers

Eric Samorodnitsky

ONCOL

SURGE

PFM

Françoise Bonnet France

Jun‐ichi Tanuma Japan

J Bouda Czechia

Simeon Springer United States

Mark A. Micale United States

Rosemary Makar United States

Christine M. Komarck United States

A. W. G. B. SMEETS Netherlands

JDA Delhanty United Kingdom

Athanassios Dellas Switzerland

Françoise Bonnet France

Eric Samorodnitsky

294 ×0.9

244 ×1.1

ONCOL

114 ×0.5

100 ×0.6

SURGE

194 ×1.7

PFM

Citations per year, relative to Eric Samorodnitsky Eric Samorodnitsky (= 1×) peers Françoise Bonnet

Countries citing papers authored by Eric Samorodnitsky

Since Specialization

Citations

This map shows the geographic impact of Eric Samorodnitsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Samorodnitsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Samorodnitsky more than expected).

Fields of papers citing papers by Eric Samorodnitsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Samorodnitsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Samorodnitsky. The network helps show where Eric Samorodnitsky may publish in the future.

Co-authorship network of co-authors of Eric Samorodnitsky

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Samorodnitsky. A scholar is included among the top collaborators of Eric Samorodnitsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Samorodnitsky. Eric Samorodnitsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaffenberger, Benjamin H., Catherine Chung, Eric Samorodnitsky, et al.. (2024). Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib. Haematologica. 109(11). 3816–3820. 1 indexed citations

Murugesan, Karthikeyan, Julie W. Reeser, Michele R. Wing, et al.. (2024). FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer. npj Precision Oncology. 8(1). 207–207. 3 indexed citations

Wing, Michele R., Julie W. Reeser, Amy Smith, et al.. (2024). A phase II telemedicine study of pemigatinib in adult patients with unresectable or metastatic pancreas cancer with FGFR2 gene fusions or other FGFR genetic alterations.. Journal of Clinical Oncology. 42(3_suppl). TPS717–TPS717.

Chen, Hui‐Zi, Russell Bonneville, Julie W. Reeser, et al.. (2021). Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy. JTO Clinical and Research Reports. 2(4). 100164–100164. 13 indexed citations

Krook, Melanie A., Max Wilberding, Kelly M. Bailey, et al.. (2020). Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma. Molecular Cancer Therapeutics. 19(3). 847–857. 106 indexed citations

Bonneville, Russell, Michele R. Wing, Melanie A. Krook, et al.. (2020). Characterization of Clonal Evolution in Microsatellite Unstable Metastatic Cancers through Multiregional Tumor Sequencing. Molecular Cancer Research. 19(3). 465–474. 7 indexed citations

Krook, Melanie A., Hui‐Zi Chen, Julie W. Reeser, et al.. (2019). Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer. Prostate Cancer and Prostatic Diseases. 22(4). 624–632. 5 indexed citations

Bonneville, Russell, Melanie A. Krook, Hui‐Zi Chen, et al.. (2019). Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing. Methods in molecular biology. 2055. 119–132. 53 indexed citations

Krook, Melanie A., Russell Bonneville, Hui‐Zi Chen, et al.. (2019). Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy. Molecular Case Studies. 5(4). a004002–a004002. 63 indexed citations

10.

Krook, Melanie A., Max Wilberding, Hui‐Zi Chen, et al.. (2019). Abstract 335: Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma. 335–335. 1 indexed citations

11.

Chen, Hui‐Zi, Russell Bonneville, Lianbo Yu, et al.. (2019). Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy. Oncotarget. 10(3). 277–288. 6 indexed citations

12.

Suarez‐Kelly, Lorena P., Keiko Akagi, Julie W. Reeser, et al.. (2018). Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity. Molecular Case Studies. 4(2). a002352–a002352. 6 indexed citations

13.

Burkart, Jarred, Dwight H. Owen, Manisha H. Shah, et al.. (2018). TargetingBRAFMutations in High-Grade Neuroendocrine Carcinoma of the Colon. Journal of the National Comprehensive Cancer Network. 16(9). 1035–1040. 27 indexed citations

14.

Datta, Jharna, Senthilkumar Damodaran, Jharna Miya, et al.. (2017). Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398. Molecular Cancer Therapeutics. 16(4). 614–624. 72 indexed citations

15.

Damodaran, Senthilkumar, Jharna Miya, Esko A. Kautto, et al.. (2015). Cancer Driver Log (CanDL). Journal of Molecular Diagnostics. 17(5). 554–559. 36 indexed citations

16.

Samorodnitsky, Eric, Raffi Hagopian, Jharna Miya, et al.. (2015). Evaluation of Hybridization Capture Versus Amplicon‐Based Methods for Whole‐Exome Sequencing. Human Mutation. 36(9). 903–914. 175 indexed citations

17.

Samorodnitsky, Eric, Jharna Datta, Raffi Hagopian, et al.. (2014). Comparison of Custom Capture for Targeted Next-Generation DNA Sequencing. Journal of Molecular Diagnostics. 17(1). 64–75. 54 indexed citations

18.

Samorodnitsky, Eric, et al.. (2014). Methylation by DNMT1 is more Efficient in Chronic Lymphocytic Lymphoma Cells than in Normal Cells. Journal of Proteomics & Bioinformatics. 1(s10). 5 indexed citations

19.

Zhdanova, Irina V., et al.. (2012). Familial Circadian Rhythm Disorder in the Diurnal Primate, Macaca mulatta. PLoS ONE. 7(3). e33327–e33327. 10 indexed citations

20.

Samorodnitsky, Eric & B. Franklin Pugh. (2010). Genome-Wide Modeling of Transcription Preinitiation Complex Disassembly Mechanisms using ChIP-chip Data. PLoS Computational Biology. 6(4). e1000733–e1000733. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact